JPRN-UMIN000002626已完成未知
Study of clinical utility of amlodipine OD 5mg tablet Chemiphar to the patients with essential hypertension - Study of clinical utility of amlodipine OD 5mg tablet Chemiphar to the patients with essential hypertension
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •upon selection of cases the following conditions are not eligible for this clinical research. The patients who are found to be excluded should be immediately discontinued the inistration of trial drugs and given appropriate treatment or switched to other drugssecondary hypertension severe hypertension systolic blood pressure above 180mmHgor diastolic blood pressure above 110mmHg or malignant hypertension patients with following circulatory diseases or symptomsheart disease myocardial infarction onset within 24 weeks prior to the consent coronary revascularization onset within 24 weeks prior to the consent valve stenosis atrial fibrillation cerebrovasculardisease stroke cerebral hemorrhage onset within 24 weeks prior to the consenttransient ischemic attack onset within 24 weeks prior to the consentvasculardiseasearteriosclerosis obliterans with symptoms such as intermittent claudication advancedhypertensive retinopathy papillary edema or hemorrhage leaching first diagnosis within 24 weeks prior to the consentTaking 3 or more types of antihypertensive drugs before obtaining consentclinically apparentliverdisorder diseases cf ast altlevel exceed 2.5 timesor above of standardclinically apparent kidney disorder diseases cf serum creatinine value exceeds 2.0mgdl or aboveuncontrolled diabetes cfHba1C10 or aboveHistory of hypersensitivity or allergy to amlodipine besylatehistory of hypersensitivity or allergy to drugshistory of alcoholism or drug abusepatients who meet exclusion criteria need to be treated prohibited combinations of drug and or therapy women who are pregnant or nursing participation in other clinical research postmarketing trials and other related tests wihtin 90 days prior to the relevant clinical research.
研究者
相似试验
已完成
不适用
A clinical study of amlodipine besilate OD tablet for the essential hypertension patients - Comparative study on the antihypertensive effect and the safety between a bland drug and a generic drugEssential hypertensionJPRN-UMIN000002144agano Kidney Evaluation Association (NKEA)100
尚未招募
2 期
Evaluation of the effect of amlodipine on chest paiIRCT20220516054874N1Mashhad University of Medical Sciences80
已完成
不适用
The study for the efficacy of amlodipine/atorvastatin combination drug in patients with type 2 diabetes complicated with hypertention and hypercholestrolemia.Type 2 diabetes complicated with hypertention and hypercholestrolemiaJPRN-UMIN000010895Kanazawa Medical University Diabetes and Endocrinology240
已完成
4 期
The effect of single tablet of fix-dose amlodipine and atorvastatin on blood pressure, lipid profile, and endothelium dependent relaxation of people with type 2 diabetes mellitusJPRN-UMIN000006063FukuiKen Saiseikai Hospital30
已完成
3 期
effects of amlodipine to reduce cardiac iron overloadMajor Thalasemia.Beta thalassemiaD56.1IRCT20190829044642N1Arak University of Medical Sciences30